文献速递临床试验与 GCP

半夏泻心汤治疗功能性消化不良(实证)的随机对照试验方案

Efficacy of Banha-sasim-tang on functional dyspepsia classified as excess pattern: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-11-09

本研究为随机、盲法、平行组临床试验,评估半夏泻心汤(BST)对比安慰剂治疗功能性消化不良(FD)实证患者的疗效,疗程4周口服给药并随访4周。主要结局为尼平消化不良指数韩文版症状问卷(NDI-K),次要结局包括生活质量、FD-QoL量表、胃肌电节律失常评估及视觉模拟量表(VAS)分析。试验结果预期提供证据表明BST可用于特定FD亚群的有效治疗。

要点

  • 随机、盲法、平行组试验,比较半夏泻心汤与安慰剂治疗FD实证患者。
  • 主要结局为NDI-K症状问卷,次要结局包括生活质量、胃肌电节律及VAS。
  • 疗程为4周口服给药,随后4周随访。

核心结论

  • 试验结果预期提供相关证据,证明半夏泻心汤可用于特定功能性消化不良亚群的有效治疗。

研究设计与样本

  • 随机、盲法、平行组临床试验,比较半夏泻心汤与安慰剂,包含4周口服给药和4周随访期。

主要发现

  • 原文未报告结果,仅描述研究方案。

关键数值与推荐

  • 主要结局指标为尼平消化不良指数韩文版症状问卷(NDI-K)。
  • 次要结局指标包括NDI-K中的生活质量评估、FD相关生活质量量表(FD-QoL)、胃肌电节律失常评估及视觉模拟量表(VAS)分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Functional dyspepsia (FD) refers to the presence of one or more gastrointestinal symptoms including postprandial fullness, epigastric pain, burning, and early satiety without an organic explanation for chronic symptoms. FD causes considerable discomfort in patients and affects their everyday activity and productivity. Because most conventional treatments have limited efficacy, numerous patients seek alternatives such as herbal medicines. In this proposed study, we will conduct a clinical trial of an herbal drug, Banha-sasim-tang (BST). Furthermore, participants will be limited to those classified as having an excess pattern by using an instrument of pattern identification for FD to determine the efficacy of BST in a specific subset of patients. METHODS: This randomized, blinded, parallel-group clinical trial of BST versus placebo will consist of 4 weeks of oral administration of BST or placebo and a 4-week follow-up period. The Korean version of the symptom-based questionnaire of the Nepean Dyspepsia Index (NDI-K) will be used as the primary outcome measure. Secondary outcome measures will include the quality-of-life (QoL) evaluation from the NDI-K, the FD-related QoL (FD-QoL) scale, assessment of gastric myoelectrical dysrhythmias (GMA), and a Visual Analog Scale (VAS) analysis. DISCUSSION: The results of this trial are expected to provide relevant evidence demonstrating that BST can be used as an effective treatment in a specific subset of FD subjects. TRIAL REGISTRATION: KCT 0002013 . Registered at Clinical Research Information Service in the Republic of Korea on 18 August 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kim YH, Kim JY, Jung SY, et al. Efficacy of Banha-sasim-tang on functional dyspepsia classified as excess pattern: study protocol for a randomized controlled trial. Trials. 2017. PMID: 29121988. doi:10.1186/s13063-017-2282-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。